Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-028605
Filing Date
2023-06-16
Accepted
2023-06-16 16:08:48
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5683
  Complete submission text file 0000950170-23-028605.txt   7075
Mailing Address C/O MIRATI THERAPEUTICS INC. 9393 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121
Business Address
BAUM CHARLES M (Reporting) CIK: 0001579824 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 231021128

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

EIN.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)